DENVER - Two Colorado marijuana users have sued a cannabis grower claiming a "patently dangerous" agricultural fungicide that becomes poisonous when ignited was applied without their knowledge to pot plants they later smoked, court documents showed on Monday.
SACRAMENTO, Calif. - Physician-assisted suicide will become legal in California under a bill signed into law on Monday by Democratic Governor Jerry Brown, despite intense opposition from some religious and disability rights groups.
ZURICH - Swiss drugmaker Roche said final survival data from a Phase III clinical trial showed the Cotellic drug used in combination with Zelboraf helped people with previously untreated BRAF V600 mutation-positive advanced melanoma live significantly longer compared to Zelboraf alone.
- General Mills Inc is recalling 1.8 million boxes of gluten-free Cheerios cereal because they may contain wheat, which can cause adverse reactions in people with gluten allergies.
- The U.S. Food and Drug Administration on Monday approved Alkermes Plc's longer-acting injectable version of blockbuster schizophrenia pill Abilify, making the treatment available in two doses.
(Reuters Health) - Medicare Advantage plans might not be meeting the needs of patients requiring the costliest and most complex levels of care, a new study suggests.
STOCKHOLM/LONDON - Three scientists from Japan, China and Ireland whose discoveries led to the development of potent new drugs against parasitic diseases including malaria and elephantiasis won the Nobel Prize for Medicine on Monday. | Video
- The U.S. Food and Drug Administration has ordered three Japanese manufacturers of duodenoscopes to conduct studies to evaluate how the devices are being used, as part of its effort to prevent the transmission of infections through the device.
(Reuters Health) - A cognitive-behavioral prevention program to prevent depressive symptoms among at-risk youth may still be effective years later, according to a new study.
- Spark Therapeutics Inc's experimental gene therapy helped improve vision in patients with a type of inherited eye disorder in a late-stage study, bringing it a step closer to becoming the first gene therapy to win U.S. approval.